Skip to content
WeighLab
Menu
Ranked #423 · Grade C

MDExam review

MDExam is a Miami-based telemedicine weight-loss provider selling compounded injectable semaglutide ($192/mo) and tirzepatide ($258/mo) bundled with coaching, operating nationwide.

Visit MDExam Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$192/mo (compounded)
Tirzepatide
$258/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,304

Tirzepatide · modeled / year

$3,096

Pricing verified August 2026

The Index scorecard

MDExam scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month56/100
Price Transparency30/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight78/100
Contract Flexibility55/100

Where the value is

  • Injectable semaglutide at $192/mo undercuts the company's own advertised '$225 as low as' floor
  • Accepts insurance for eligible patients in addition to cash-pay options
  • 100% refund offered if a patient doesn't qualify after evaluation
  • Nationwide telemedicine coverage across all 50 states from a single Miami HQ

The tradeoffs

  • The site's own headline claim ('priced as low as $225/month') doesn't match either actual product price — tirzepatide at $258/mo is more expensive than the claimed floor, which should make a shopper distrust the headline number generally
  • No specific dose is disclosed for either the $192 or $258 figure, making it impossible to know what's actually being compared
  • No compounding pharmacy is named anywhere on the site
  • No named medical director and no LegitScript badge found on any page reviewed
  • The '93% success rate' and '86,000+ patients served' statistics are self-reported marketing claims with no independent source cited

The bottom line

Best for: Cost-first shoppers who want a lower injectable-semaglutide starting price than the site's own headline claim advertises. MDExam is a Miami-based telemedicine weight-loss provider selling compounded injectable semaglutide ($192/mo) and tirzepatide ($258/mo) bundled with coaching, operating nationwide.

Ranked #423 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to MDExam.

The 24 programs nearest this one

Pricing, states and verification reflect MDExam's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on MDExam's site. Not medical advice; see our disclosure.

← Back to the value leaderboard